Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Ligand Binding Sites02:40

Ligand Binding Sites

12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

161
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
161
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine Learning-Based Models to Predict Drug-Induced Liver Injury (DILI) to Assist Medicinal Chemistry.

Journal of medicinal chemistry·2026
Same author

Corrigendum to "Synthesis and biological evaluation of mixed aryl-alkyl succinates as modulators of autophagy and apoptosis in gastric carcinoma" [Bioorg. Chem. 179 (2026) 109997].

Bioorganic chemistry·2026
Same author

Where do we go from here? Current state of drug-target binding kinetics and a roadmap to their establishment in drug discovery campaigns.

Drug discovery today·2026
Same author

Combinatorial histone modifications direct ATP-dependent chromatin remodeling by NURF to promoter-proximal nucleosomes.

Nucleic acids research·2026
Same author

Synthesis and biological evaluation of mixed aryl-alkyl succinates as modulators of autophagy and apoptosis in gastric carcinoma.

Bioorganic chemistry·2026
Same author

Conformational Remodeling Underlies Activity Loss in Disease-Linked Asparagine Synthetase Variant.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 23, 2025

Author Spotlight: Advancing Structural and Biochemical Studies of Proteins Through Thermal Shift Assays
03:09

Author Spotlight: Advancing Structural and Biochemical Studies of Proteins Through Thermal Shift Assays

Published on: August 9, 2024

646

Increased throughput in methods for simulating protein ligand binding and unbinding.

Syeda Rehana Zia1, Adriana Coricello2, Giovanni Bottegoni3

  • 1Department of Paediatrics and Child Health, Faculty of Health Sciences, Medical College, The Aga Khan University, Karachi, 74800, Pakistan.

Current Opinion in Structural Biology
|June 26, 2024
PubMed
Summary
This summary is machine-generated.

Molecular dynamics methods offer detailed insights into protein-ligand interactions, crucial for drug discovery. Recent advancements enhance efficiency and accuracy using advanced sampling and machine learning techniques.

More Related Videos

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.3K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

537

Related Experiment Videos

Last Updated: Jun 23, 2025

Author Spotlight: Advancing Structural and Biochemical Studies of Proteins Through Thermal Shift Assays
03:09

Author Spotlight: Advancing Structural and Biochemical Studies of Proteins Through Thermal Shift Assays

Published on: August 9, 2024

646
Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
13:57

Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects

Published on: February 18, 2014

29.3K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

537

Area of Science:

  • Computational chemistry
  • Biophysics
  • Pharmacology

Background:

  • Molecular dynamics (MD) simulations provide atomic-level insights into protein-ligand binding mechanisms.
  • Key parameters like binding free energies and residence times can be quantified.
  • Current MD methods are often limited by computationally intensive, time-consuming simulations, hindering high-throughput drug discovery.

Purpose of the Study:

  • To survey recent advancements in molecular dynamics methods for protein-ligand binding/unbinding studies.
  • To highlight strategies that improve the efficiency and throughput of these simulations.
  • To assess the accuracy and applicability of these enhanced methods in drug discovery contexts.

Main Methods:

  • Utilizing enhanced sampling techniques to accelerate molecular dynamics simulations.
  • Employing carefully selected collective variables to describe protein-ligand interactions.
  • Integrating machine learning approaches to optimize simulation efficiency and data analysis.
  • Validating methods on systems relevant to real-world drug discovery challenges.

Main Results:

  • Recent implementations successfully enhance the efficiency of MD simulations for protein-ligand binding.
  • These improved methods maintain accuracy in quantifying critical binding parameters.
  • Validation on drug discovery-relevant systems demonstrates practical utility.
  • The combination of enhanced sampling, collective variables, and machine learning is key to efficiency gains.

Conclusions:

  • Advanced molecular dynamics methods are becoming more efficient for drug discovery.
  • These techniques provide crucial molecular-level mechanistic details for ligand binding.
  • The integration of machine learning and enhanced sampling shows significant promise for accelerating the drug discovery pipeline.